Blood conservation in cardiac surgery: the Virginia Commonwealth University (VCU) experience.
Green
Jeffrey A
JA
Department of Anesthesiology, Virginia Commonwealth University, Richmond, VA, USA. jagreen2@vcu.edu
D000328:Adult; D015119:Aminocaproic Acid / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001803:Blood Transfusion / Q000191:economics / Q000295:instrumentation / Q000379:methods*; D001804:Blood Transfusion, Autologous / Q000191:economics / Q000295:instrumentation / Q000379:methods*; D006348:Cardiac Surgical Procedures; D003363:Cost Control; D003657:Decision Making; D017707:Erythrocyte Transfusion; D004921:Erythropoietin / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005260:Female; D005340:Fibrinogen / Q000627:therapeutic use; D005353:Fibronectins / Q000627:therapeutic use; D006400:Hematocrit; D006438:Hemodilution; D006493:Heparin / Q000627:therapeutic use; D006785:Hospitals, University; D006801:Humans; D008297:Male; D010949:Plasma; D017713:Platelet Transfusion; D017410:Practice Guidelines as Topic; D016896:Treatment Outcome; D014768:Virginia
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D005353:Fibronectins; C026912:cryoprecipitate coagulum; D004921:Erythropoietin; D005169:Factor VIII; D005340:Fibrinogen; D006493:Heparin; D015119:Aminocaproic Acid